FDA grants De Novo marketing authorisation to GT Metabolic Solutions for its magnet compression anastomosis technology
Ten years in endobariatrics – the past, present and future
Olympus launches new Powerseal Sealer/Divider 5mm devices extending advanced bipolar surgical energy portfolio
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity
FDA expands Ethicon’s Linx Reflux Management System to include patients with Barrett’s esophagus experiencing GERD
ANSM suspends Allurion gastric balloons in France
FDA grants Breakthrough Device Designation for Fractyl’s Revita in weight maintenance for people with obesity who discontinue GLP-1s
Phenomix launches personalised obesity care genetic testing available to women in with Hello Alpha partnership
ReShape Lifesciences sells obesity devices to Biorad Medisys
iHerb launches new GLP-1 support products designed to combat common side effects from rapid weight loss
